Last updated: June 2, 2026
MONISTAT 7 suppliers: who manufactures the active ingredient, private-label, and finished-goods supply chain
Executive summary: MONISTAT 7 (miconazole nitrate, intravaginal antifungal) is supplied in the US as a finished, OTC product by Bayer under the MONISTAT brand. Upstream chemical and packaging supply is typically handled through Bayer’s established procurement network, with miconazole nitrate sourcing from specialized API or intermediates suppliers and finished-pack sourcing from contract manufacturers, distributors, and repackagers. Public, product-specific supplier disclosure is limited; the most reliable “supplier” data in practice comes from FDA product listings, label/marketing-authority holders, and authorized distributor networks rather than named component suppliers.
Who manufactures MONISTAT 7 (miconazole nitrate) in finished form?
- Brand/label holder: Bayer (MONISTAT brand; OTC intravaginal antifungal).
- Finished dosage form: intravaginal cream/insert product line marketed as MONISTAT 7 (commonly associated with a 7-day regimen for vaginal candidiasis).
- Distribution model: OTC finished goods are typically sourced through Bayer’s finished-goods supply chain and sold via wholesale distributors to retail pharmacy and e-commerce.
Which FDA-linked entities appear as MONISTAT 7 drug product manufacturers?
The FDA’s structured drug listing records the applicant/labeler and manufacturing/labeling facilities tied to the marketed National Drug Code (NDC) products. For “supplier” diligence, the operational approach is to use:
- NDC-specific FDA drug listing to identify labeler/manufacturer and facility identifiers.
- Label copy for the “Manufactured for” / “Distributed by” statements that name the marketing entity tied to that NDC.
Limitation that impacts supplier mapping: component-level vendors (miconazole nitrate API suppliers, tubing/tube suppliers, secondary carton printers) are rarely disclosed on OTC packaging in a way that is searchable at the shelf-item level.
What are the main upstream suppliers for miconazole nitrate used in MONISTAT 7?
Upstream supply generally bifurcates into:
- API or key intermediate supply for miconazole nitrate
- Formulation and packaging supply for the finished intravaginal product
For miconazole nitrate, global supply tends to concentrate among firms that can produce or source:
- miconazole base
- nitration/nitrate salt form compatible with vaginal formulation requirements
- controlled particle/impurity profiles for stability and potency consistency
In practice for due diligence, buyers identify these suppliers via:
- API manufacturer questionnaires
- COA patterns and change-control history
- FDA facility inspections tied to drug substance manufacturing sites (when discoverable)
Are contract manufacturers used for MONISTAT 7 cream/insert products?
For OTC dermatology/gynecology products like MONISTAT, the finished-goods manufacturing footprint can include:
- Bayer-owned manufacturing sites, and/or
- CMOs that produce and fill intravaginal creams for brand owners
The most actionable way to determine whether a CMO is involved is to map:
- the NDC’s labeled manufacturer facility (facility ID where available)
- any site change notes in FDA submissions or labeling history
- consistency of supplier/packaging specs across lot codes
Which packaging and logistics suppliers support MONISTAT 7 production?
Finished OTC intravaginal products typically require:
- collapsible tubes or applicators (primary)
- inner seals, caps, and applicator components (if applicable)
- cartons, leaflets/IFUs, barcoding labels (secondary/tertiary)
- palletization and distribution warehousing
These are usually handled by Bayer’s procurement network and/or contracted packaging manufacturers. Public sources rarely name specific packaging vendors unless they are disclosed on:
- labeling “Manufactured for” statements
- regulatory submissions tied to facility listings
- environmental/quality disclosures
MONISTAT 7 NDC and label-holder mapping: how to identify the actual “supplier” at the shelf level
Key point: “Supplier” depends on whether the buyer means:
- finished-goods maker (site producing/tub-filling product)
- labeler/marketer (entity responsible for OTC drug listing)
- distributor (wholesale channel)
- API vendor (miconazole nitrate source)
For operational decision-making, the shelf-level path is NDC-based.
What to extract from MONISTAT 7 product listings
- NDC(s) marketed as MONISTAT 7
- Labeler/applicant
- Manufacturing site(s) for:
- drug product
- packaging/labelling
- Contact/managing entity shown in the listing and on carton labeling
What distribution routes typically serve MONISTAT 7
- national wholesale distributors (pharmacy channel)
- large retail pharmacy chains
- direct-to-retail and e-commerce fulfillment via Bayer or contracted logistics providers
How does MONISTAT 7 supply compare with other miconazole OTC vaginal products?
Competitive supply similarity: Most branded and store-brand “miconazole nitrate intravaginal” products in the US are built on the same core value chain:
- miconazole nitrate salt supply
- formulation into cream and/or applicator-ready dosage
- OTC packaging compliant with FDA OTC monograph/labeling requirements
Differentiator in supplier mapping: labeler/manufacturer facility and packaging configuration can vary by NDC, even when API is effectively the same salt form.
Key Takeaways
- MONISTAT 7 is a Bayer-labeled OTC product in the US; finished-goods supply is through Bayer’s established procurement/manufacturing network.
- Public “supplier” identification is most reliably done via NDC-based FDA drug listing and carton/label “manufactured for/distributed by” statements.
- Upstream miconazole nitrate suppliers are usually not disclosed on OTC packaging; API sourcing is best identified through FDA facility mappings, change-control histories, and COA/QA documentation.
- Contract manufacturing involvement (CMO vs Bayer site) is NDC-facility dependent and should be verified at the facility-listing level.
FAQs
1) Who is the labeler for MONISTAT 7 in the US?
Bayer is the MONISTAT brand labeler/marketer for MONISTAT 7.
2) What ingredient makes up MONISTAT 7?
MONISTAT 7 contains miconazole nitrate as the antifungal active ingredient.
3) Are there different manufacturers for MONISTAT 7 by NDC?
Yes. OTC products can have different manufacturing or packaging facilities across NDCs, even for the same strength and regimen branding.
4) Do private-label versions of miconazole nitrate intravaginal products use the same suppliers?
Often they share upstream API sourcing patterns for miconazole nitrate, but finished-goods manufacturing and packaging suppliers typically differ by labeler and NDC.
5) How can a buyer confirm the finished-goods manufacturing site for a specific MONISTAT 7 package?
Use the product’s NDC to query FDA drug listing/manufacturing facility information and cross-check with the carton labeling “manufactured for” and facility identifiers.
References (APA)
- FDA. (n.d.). Drugs@FDA. US Food and Drug Administration. https://www.accessdata.fda.gov/scripts/cder/daf/
- FDA. (n.d.). OpenFDA Drug Listing Data. US Food and Drug Administration. https://open.fda.gov/
